MEK162 in Combination With Imatinib Mesylate in Patients With Untreated

See also
Status	Clinical Trial	Phase
Completed	`NCT02574663` - TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors	Phase 1
Completed	`NCT01135849` - B-Receptor Signaling in Cardiomyopathy	N/A
Completed	`NCT00623831` - A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen	Phase 1
Completed	`NCT00464620` - Trial of Dasatinib in Advanced Sarcomas	Phase 2
Completed	`NCT01294202` - A Study to Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GIST	Phase 2
Completed	`NCT00785785` - A Study of Nilotinib Versus Imatinib in GIST Patients	Phase 3
Recruiting	`NCT02443948` - Circulating Cell-free Tumor DNA in the Plasma of Patients With Gastrointestinal Stromal Tumors (GIST)	N/A
Recruiting	`NCT01034670` - Advanced Gastrointestinal Endoscopic Imaging	N/A
Completed	`NCT00867113` - Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST)	Phase 2
Active, not recruiting	`NCT01391611` - Pazopanib in Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors (GIST)	Phase 2
Terminated	`NCT02452424` - A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors	Phase 1/Phase 2
Recruiting	`NCT03594422` - A Study of HQP1351 in Patients With GIST or Other Solid Tumors	Phase 1
Recruiting	`NCT05453292` - Endoscopic Ultrasound Radiofrequency Ablation for GISTs	N/A
Completed	`NCT00780494` - Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma	Phase 2
Recruiting	`NCT04557969` - Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis
Completed	`NCT03404076` - Unifying Advanced Treatment With Advanced Imaging
Recruiting	`NCT04821895` - Oncogenetic Panel and Integrated Clinical Data Registry Study for Wild Type Gastrointestinal Stromal Tumor Patients
Completed	`NCT01316263` - A Study of IMC-3G3 in Previously Treated Patients With Unresectable and/or Metastatic Gastrointestinal Stromal Tumors	Phase 2
Terminated	`NCT00767234` - Permission to Collect Blood Over Time for Research	N/A
Recruiting	`NCT01048281` - Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

NCT number	NCT01991379
Study type	Interventional
Source	Memorial Sloan Kettering Cancer Center
Contact
Status	Active, not recruiting
Phase	Phase 1/Phase 2
Start date	November 2013
Completion date	November 2024

MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms